Cas9 must be localized to the nucleus to access the genome of mammalian cells. For most proteins, adding a single nuclear localization signal (NLS) is sufficient to promote nuclear entry. However, Cas9 nuclear entry appears to be inefficient as multiple NLSs are typically added to Cas9. Here, we found that three different Cas9 variants interact with the ribosome in HEK293T cells, and that this interaction is RNA mediated. Following immunoprecipitation-mass spectrometry of cytoplasmic-localized Cas9-0NLS and nuclear-localized Cas9-4NLS constructs, we identified novel Cas9 interactors in postmitotic neurons, including KEAP1 and additional ribosomal subunits, the latter were enriched in Cas9-0NLS samples. Collectively, our results suggest that Cas9 is sequestered in the cytoplasm of mammalian cells, in part, via interaction with the ribosome. Increasing the number of NLSs on Cas9 and/or increasing the amount of cytoplasmic guide RNA has the potential to outcompete ribosomal RNA binding and promote efficient nuclear localization of CRISPR-Cas9 variants.
Get full access to this article
View all access options for this article.
References
1.
PourcelC, SalvignolG, VergnaudG. CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology (Reading), 2005; 151(Pt 3):653–663; doi: 10.1099/mic.0.27437-0
2.
MojicaFJ, Díez-VillaseñorC, García-MartínezJ, et al.Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol, 2005; 60(2):174–182; doi: 10.1007/s00239-004-0046-3
3.
BolotinA, QuinquisB, SorokinA, et al.Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology (Reading), 2005; 151(Pt 8):2551–2561; doi: 10.1099/mic.0.28048-0
4.
JinekM, ChylinskiK, FonfaraI, et al.A programmable Dual-RNA–Guided DNA endonuclease in adaptive bacterial immunity. Science, 2012; 337(6096):816–821; doi: 10.1126/science.1225829
5.
RanFA, HsuPD, WrightJ, et al.Genome engineering using the CRISPR-Cas9 system. Nat Protoc, 2013; 8(11):2281–2308; doi: 10.1038/nprot.2013.143
6.
MaliP, YangL, EsveltKM, et al.RNA-guided human genome engineering via Cas9. Science, 2013; 339(6121):823–826; doi: 10.1126/science.1232033
7.
CongL, RanFA, CoxD, et al.Multiplex genome engineering using CRISPR/Cas systems. Science, 2013; 339(6121):819–823; doi: 10.1126/science.1231143
8.
JinekM, EastA, ChengA, et al.RNA-programmed genome editing in human cells. Elife, 2013; 2:e00471; doi: 10.7554/eLife.00471
9.
SchmidtC, LipsiusE, KruppaJ. Nuclear and nucleolar targeting of human ribosomal protein S6. Mol Biol Cell, 1995; 6(12):1875–1885; doi: 10.1091/mbc.6.12.1875
10.
WilliamsSC, AngererND, JohnsonPF. C/EBP proteins contain nuclear localization signals imbedded in their basic regions. Gene Expr, 1997; 6(6):371–385.
11.
MoedeT, LeibigerB, PourHG, et al.Identification of a nuclear localization signal, RRMKWKK, in the homeodomain transcription factor PDX-1. FEBS Lett, 1999; 461(3):229–234; doi: 10.1016/S0014-5793(99)01446-5
12.
HessabiB, ZieglerP, SchmidtI, et al.The nuclear localization signal (NLS) of PDX-1 is part of the homeodomain and represents a novel type of NLS. Eur J Biochem, 1999; 263(1):170–177; doi: 10.1046/j.1432-1327.1999.00481.x
13.
MaertensG, CherepanovP, DebyserZ, et al.Identification and characterization of a functional nuclear localization signal in the HIV-1 integrase interactor LEDGF/p75. J Biol Chem, 2004; 279(32):33421–33429; doi: 10.1074/jbc.M404700200
14.
MajerciakV, YamanegiK, NieSH, et al.Structural and functional analyses of Kaposi sarcoma-associated herpesvirus ORF57 nuclear localization signals in living cells. J Biol Chem, 2006; 281(38):28365–28378; doi: 10.1074/jbc.M603095200
15.
LuJ, WuT, ZhangB, et al.Types of nuclear localization signals and mechanisms of protein import into the nucleus. Cell Commun Signal, 2021; 19(1):60; doi: 10.1186/s12964-021-00741-y
16.
LangeA, MillsRE, LangeCJ, et al.Classical nuclear localization signals: Definition, function, and interaction with importin α *. J Biol Chem, 2007; 282(8):5101–5105; doi: 10.1074/jbc.R600026200
17.
CollasP, AleströmP. Nuclear localization signal of SV40 T antigen directs import of plasmid DNA into sea urchin male pronuclei in vitro. Mol Reprod Dev, 1996; 45(4):431–438; doi: 10.1002/(SICI)1098-2795(199612)45:4<431::AID-MRD4>3.0.CO;2-S
18.
ChatterjeeS, JavierM, StochajU. In vivo analysis of nuclear protein traffic in mammalian cells. Exp Cell Res, 1997; 236(1):346–350; doi: 10.1006/excr.1997.3746
19.
HouZ, ZhangY, PropsonNE, et al.Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc Natl Acad Sci USA, 2013; 110(39):15644–15649; doi: 10.1073/pnas.1313587110
20.
AouidaM, EidA, AliZ, et al.Efficient fdCas9 synthetic endonuclease with improved specificity for precise genome engineering. PLoS One, 2015; 10(7):e0133373; doi: 10.1371/journal.pone.0133373
21.
SuzukiK, TsunekawaY, Hernandez-BenitezR, et al.In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration. Nature, 2016; 540(7631):144–149; doi: 10.1038/nature20565
22.
ZhouW, CuiH, YingL, et al.Enhanced cytosolic delivery and release of CRISPR/Cas9 by black phosphorus nanosheets for genome editing. Angew Chem Int Ed Engl, 2018; 57(32):10268–10272; doi: 10.1002/anie.201806941
23.
KoblanLW, DomanJL, WilsonC, et al.Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat Biotechnol, 2018; 36(9):843–846; doi: 10.1038/nbt.4172
24.
IbraheimR, SongCQ, MirA, et al.All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo. Genome Biol, 2018; 19(1):137; doi: 10.1186/s13059-018-1515-0
25.
MiH, MuruganujanA, HuangX, et al.Protocol update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0). Nat Protoc, 2019; 14(3):703–721; doi: 10.1038/s41596-019-0128-8
26.
WuY, ZengJ, RoscoeBP, et al.Highly efficient therapeutic gene editing of human hematopoietic stem cells. Nat Med, 2019; 25(5):776–783; doi: 10.1038/s41591-019-0401-y
27.
StaahlBT, BenekareddyM, Coulon-BainierC, et al.Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes. Nat Biotechnol, 2017; 35(5):431–434; doi: 10.1038/nbt.3806
28.
LiuP, LiangSQ, ZhengC, et al.Improved prime editors enable pathogenic allele correction and cancer modelling in adult Mice. Nat Commun, 2021; 12(1):2121; doi: 10.1038/s41467-021-22295-w
29.
MaggioI, ZittersteijnHA, WangQ, et al.Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components. Gene Ther, 2020; 27(5):209–225; doi: 10.1038/s41434-019-0119-y
30.
IbraheimR, TaiPWL, MirA, et al.Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo. Nat Commun, 2021; 12(1):6267; doi: 10.1038/s41467-021-26518-y
31.
ShuiS, WangS, LiuJ. Systematic investigation of the effects of multiple SV40 nuclear localization signal fusion on the genome editing activity of purified SpCas9. Bioengineering (Basel), 2022; 9(2); doi: 10.3390/bioengineering9020083
32.
LukK, LiuP, ZengJ, et al.Optimization of nuclear localization signal composition improves CRISPR-Cas12a editing rates in human primary cells. GEN Biotechnol, 2022; 1(3):271–284; doi: 10.1089/genbio.2022.0003
33.
LiuP, LukK, ShinM, et al.Enhanced Cas12a editing in mammalian cells and zebrafish. Nucleic Acids Res, 2019; 47(8):4169–4180; doi: 10.1093/nar/gkz184
34.
HuP, ZhaoX, ZhangQ, et al.Comparison of various nuclear localization signal-fused Cas9 proteins and Cas9 mRNA for genome editing in Zebrafish. G3 (Bethesda), 2018; 8(3):823–831; doi: 10.1534/g3.117.300359
35.
NasoMF, TomkowiczB, PerryWL3rd, et al.Adeno-Associated Virus (AAV) as a vector for gene therapy. BioDrugs, 2017; 31(4):317–334; doi: 10.1007/s40259-017-0234-5
36.
HuangH-S, AllenJA, MabbAM, et al.Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons. Nature, 2011; 481(7380):185–189; doi: 10.1038/nature10726
37.
SanjanaNE, ShalemO, ZhangF. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods, 2014; 11(8):783–784; doi: 10.1038/nmeth.3047
38.
NissimL, PerliSD, FridkinA, et al.Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells. Mol Cell, 2014; 54(4):698–710; doi: 10.1016/j.molcel.2014.04.022
39.
KimHK, SongM, LeeJ, et al.In vivo high-throughput profiling of CRISPR-Cpf1 activity. Nat Methods, 2017; 14(2):153–159; doi: 10.1038/nmeth.4104
40.
RanFA, CongL, YanWX, et al.In vivo genome editing using Staphylococcus aureus Cas9. Nature, 2015; 520(7546):186–191; doi: 10.1038/nature14299
41.
GaoY, HiseyE, BradshawTWA, et al.Plug-and-Play protein modification using homology-independent universal genome engineering. Neuron, 2019; 103(4):583–597.e8; doi: 10.1016/j.neuron.2019.05.047
42.
EitasTK, SteppWH, SjeklochaL, et al.Differential regulation of innate immune cytokine production through pharmacological activation of nuclear factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes. PLoS One, 2017; 12(9):e0184164; doi: 10.1371/journal.pone.0184164
43.
ChenJ, SuS, Pickar-OliverA, et al.Engineered Cas9 variants bypass Keap1-mediated degradation in human cells and enhance epigenome editing efficiency. Nucleic Acids Res, 2024; 52(19):11536–11551; doi: 10.1093/nar/gkae761
44.
TyanovaS, TemuT, SinitcynP, et al.The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods, 2016; 13(9):731–740; doi: 10.1038/nmeth.3901
45.
ThomasPD, EbertD, MuruganujanA, et al.PANTHER: Making genome-scale phylogenetics accessible to all. Protein Sci, 2022; 31(1):8–22; doi: 10.1002/pro.4218
46.
Perez-RiverolY, BaiJ, BandlaC, et al.The PRIDE database resources in 2022: A hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res, 2022; 50(D1):D543–D552; doi: 10.1093/nar/gkab1038
47.
FischerU, MichaelWM, LührmannR, et al.Signal-mediated nuclear export pathways of proteins and RNAs. Trends Cell Biol, 1996; 6(8):290–293; doi: 10.1016/0962-8924(96)20030-3
48.
la CourT, KiemerL, MølgaardA, et al.Analysis and prediction of leucine-rich nuclear export signals. Protein Eng Des Sel, 2004; 17(6):527–536; doi: 10.1093/protein/gzh062
49.
KosugiS, YanagawaH, TerauchiR, et al.NESmapper: Accurate prediction of leucine-rich nuclear export signals using activity-based profiles. PLoS Comput Biol, 2014; 10(9):e1003841.
50.
XuD, MarquisK, PeiJ, et al.LocNES: A computational tool for locating classical NESs in CRM1 cargo proteins. Bioinformatics, 2015; 31(9):1357–1365; doi: 10.1093/bioinformatics/btu826
51.
Latré de LatéP, PépinA, Assaf-VandecasteeleH, et al.Glucocorticoid-Induced Leucine Zipper (GILZ) promotes the nuclear exclusion of FOXO3 in a Crm1-dependent Manner. J Biol Chem, 2010; 285(8):5594–5605; doi: 10.1074/jbc.M109.068346
WolffB, SanglierJ-J, WangY. Leptomycin B is an inhibitor of nuclear export: Inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem Biol, 1997; 4(2):139–147; doi: 10.1016/S1074-5521(97)90257-X
54.
HarhajEW, SunS-C. Regulation of RelA subcellular localization by a putative nuclear export signal and p50. Mol Cell Biol, 1999; 19(10):7088–7095; doi: 10.1128/MCB.19.10.7088
55.
TanR, DuW, LiuY, et al.Nucleolus localization of SpyCas9 affects its stability and interferes with host protein translation in mammalian cells. Genes Dis, 2022; 9(3):731–740; doi: 10.1016/j.gendis.2020.09.003
56.
LamYW, LamondAI, MannM, et al.Analysis of nucleolar protein dynamics reveals the nuclear degradation of ribosomal proteins. Curr Biol, 2007; 17(9):749–760; doi: 10.1016/j.cub.2007.03.064
YusupovMM, YusupovaGZ, BaucomA, et al.Crystal structure of the ribosome at 5.5 Å resolution. Science, 2001; 292(5518):883–896.
59.
CarterAP, ClemonsWM, BrodersenDE, et al.Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature, 2000; 407(6802):340–348; doi: 10.1038/35030019
60.
RedonS, ReichenbachP, LingnerJ. Protein–RNA and protein–protein interactions mediate association of human EST1A/SMG6 with telomerase. Nucleic Acids Res, 2007; 35(20):7011–7022; doi: 10.1093/nar/gkm724
61.
CaoY, WoodsonSA. Destabilizing effect of an rRNA stem-loop on an attenuator hairpin in the 5′ exon of the Tetrahymena pre-rRNA. Rna, 1998; 4(8):901–914; doi: 10.1017/s1355838298980621
62.
NishimasuH, RanFA, HsuPD, et al.Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell, 2014; 156(5):935–949; doi: 10.1016/j.cell.2014.02.001
63.
FerdosiSR, EwaishaR, MoghadamF, et al.Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes. Nat Commun, 2019; 10(1):1842; doi: 10.1038/s41467-019-09693-x
64.
KunkelGR, MaserRL, CalvetJP, et al.U6 small nuclear RNA is transcribed by RNA polymerase III. Proc Natl Acad Sci U S A, 1986; 83(22):8575–8579; doi: 10.1073/pnas.83.22.8575
65.
ShawWM, StudenáL, RoyK, et al.Inducible expression of large gRNA arrays for multiplexed CRISPRai applications. Nat Commun, 2022; 13(1):4984; doi: 10.1038/s41467-022-32603-7
66.
XuL, ZhaoL, GaoY, et al.Empower multiplex cell and tissue-specific CRISPR-mediated gene manipulation with self-cleaving ribozymes and tRNA. Nucleic Acids Res, 2017; 45(5):e28-e28; doi: 10.1093/nar/gkw1048
ProtterDSW, ParkerR. Principles and properties of stress granules. Trends Cell Biol, 2016; 26(9):668–679; doi: 10.1016/j.tcb.2016.05.004
70.
KedershaNL, GuptaM, LiW, et al.RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J Cell Biol, 1999; 147(7):1431–1442; doi: 10.1083/jcb.147.7.1431
71.
GleesP, MellerK. The finer structure of synapses and Neurones. A review of recent electronmicroscopical studies. Paraplegia, 1964; 2:77–95; doi: 10.1038/sc.1964.17
FuscoCM, DeschK, DörrbaumAR, et al.Neuronal ribosomes exhibit dynamic and context-dependent exchange of ribosomal proteins. Nat Commun, 2021; 12(1):6127; doi: 10.1038/s41467-021-26365-x
74.
WolterJM, MaoH, FragolaG, et al.Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA. Nature, 2020; 587(7833):281–284; doi: 10.1038/s41586-020-2835-2
75.
SchmidRS, DengX, PanikkerP, et al.CRISPR/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice. J Clin Invest, 2021; 131(5); doi: 10.1172/JCI142574
76.
PhilippidisA. CASGEVY Makes History as FDA Approves First CRISPR/Cas9 genome edited therapy. Hum Gene Ther, 2024; 35(1–2):1–4; doi: 10.1089/hum.2023.29263.bfs
77.
PierceEA, AlemanTS, JayasunderaKT, et al.Gene editing for CEP290-Associated retinal degeneration. N Engl J Med, 2024; 390(21):1972–1984; doi: 10.1056/NEJMoa2309915
78.
LeppekK, DasR, BarnaM. Functional 5′ UTR mRNA structures in eukaryotic translation regulation and how to find them. Nat Rev Mol Cell Biol, 2018; 19(3):158–174; doi: 10.1038/nrm.2017.103
79.
ZhukovaM, SchedlP, ShidlovskiiYV. The role of secondary structures in the functioning of 3′ untranslated regions of mRNA. BioEssays, 2024; 46(3):2300099; doi: 10.1002/bies.202300099
80.
MehtaM, RaguramanR, RameshR, et al.RNA Binding Proteins (RBPs) and their role in DNA damage and radiation response in cancer. Adv Drug Deliv Rev, 2022; 191:114569; doi: 10.1016/j.addr.2022.114569
81.
NellesDA, FangMY, O’ConnellMR, et al.Programmable RNA Tracking In Live Cells With CRISPR/Cas9. Cell, 2016; 165(2):488–496; doi: 10.1016/j.cell.2016.02.054
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
